Measures of fibromyalgia: Fibromyalgia Impact Questionnaire (FIQ), Brief Pain Inventory (BPI), Multidimensional Fatigue Inventory (MFI-20), Medical Outcomes Study (MOS) Sleep Scale, and Multiple Ability Self-Report Questionnaire (MASQ)

Arthritis Care and Research

Volumn 63, Issue SUPPL. 11, 2011, Pages

  Williams, David A ^a   Arnold, Lesley M ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRIEF PAIN INVENTORY; CLINICAL PRACTICE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; HUMAN; MEASUREMENT; MEDICAL OUTCOME STUDY SLEEP SCALE; MULTIDIMENSIONAL FATIGUE INVENTORY; MULTIPLE ABILITY SELF REPORT QUESTIONNAIRE; PSYCHOMETRY; QUESTIONNAIRE; RATING SCALE; RELIABILITY; RHEUMATOLOGY; VALIDITY;

FATIGUE; FIBROMYALGIA; HUMANS; PAIN MEASUREMENT; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF REPORT; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 80755181038     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20531     Document Type: Article

References (55)

1. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010; 62: 600-10.
2. Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L, et al. Patient perspectives on the impact of fibromyalgia. Patient Educ Couns 2008; 73: 114-20.
3. Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L, et al. Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum 2008; 59: 952-60. (Pubitemid 351990991)
4. Arnold LM, Mease PJ, Williams DA, Martin SA, Wang F, Emir B, et al. Development of responder definitions for fibromyalgia clinical trials. Arthritis Rheum 2010; 62: S38.
5. Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol 2010; 63: 1179-94.
6. Bennett RM,. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 2005; 23: S154-62.
7. Burckhardt CS, Clark SR, Bennett RM,. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991; 18: 728-33.
8. Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL,. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 2009; 11: R120.
9. Wolfe F, Hawley DJ, Goldenberg DL, Russell IJ, Buskila D, Neumann L,. The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment Questionnaire. J Rheumatol 2000; 27: 1989-99. (Pubitemid 30670493)
10. Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005; 119: 5-15. (Pubitemid 41752960)
11. Arnold LM, Russell IJ, Diri EW, Duan WR, Young JP Jr, Sharma U,. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain 2008; 9: 792-805.
12. Arnold LM, Gendreau RM, Palmer RH, Gendreau JF, Wang Y,. Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2010; 62: 2745-56.
13. Arnold LM, Clauw DJ, Wohlreich MM, Wang F, Ahl J, Gaynor PJ, et al. Efficacy of duloxetine in patients with fibromyalgia: pooled analysis of 4 placebo-controlled clinical trials. Prim Care Companion J Clin Psychiatry 2009; 11: 237-44.
14. Bennett RM, Bushmakin AG, Cappelleri JC, Zlateva G, Sadosky AB,. Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol 2009; 36: 1304-11.
15. Cleeland CS,. Measurement and prevalence of pain in cancer. Semin Oncol Nurs 1985; 1: 87-92.
16. Daut RL, Cleeland CS, Flanery RC,. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983; 17: 197-210. (Pubitemid 13012221)
17. Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS,. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 2004; 20: 309-18. (Pubitemid 39108843)
18. Tan G, Jensen MP, Thornby JI, Shanti BF,. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain 2004; 5: 133-7. (Pubitemid 38850184)
19. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005; 113: 9-19. (Pubitemid 40038441)
20. Williams VS, Smith MY, Fehnel SE,. The validity and utility of the BPI interference measures for evaluating the impact of osteoarthritic pain. J Pain Symptom Manage 2006; 31: 48-57. (Pubitemid 43143298)
21. Radbruch L, Loick G, Kiencke P, Lindena G, Sabatowski R, Grond S, et al. Validation of the German version of the Brief Pain Inventory. J Pain Symptom Manage 1999; 18: 180-7. (Pubitemid 29459123)
22. Mendoza T, Mayne T, Rublee D, Cleeland C,. Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis. Eur J Pain 2006; 10: 353-61.
23. Cleeland C,. The Brief Pain Inventory: user guide. Houston: MD Anderson Cancer Center; 2009.
24. Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL,. Defining the clinically important difference in pain outcome measures. Pain 2000; 88: 287-94.
25. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM,. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94: 149-58. (Pubitemid 33016608)
26. Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003; 106: 337-45. (Pubitemid 37505881)
27. Mease PJ, Spaeth M, Clauw DJ, Arnold LM, Bradley LA, Russell IJ, et al. Estimation of minimum clinically important difference for pain in fibromyalgia. Arthritis Care Res (Hoboken) 2011; 63: 821-6.
28. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008; 9: 105-21. (Pubitemid 351147828)
29. Smets EM, Garssen B, Bonke B, De Haes JC,. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995; 39: 315-25.
30. Smets EM, Garssen B, Cull A, de Haes JC,. Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer 1996; 73: 241-5. (Pubitemid 26028340)
31. Barendregt PJ, Visser MR, Smets EM, Tulen JH, van den Meiracker AH, Boomsma F, et al. Fatigue in primary Sjogren's syndrome. Ann Rheum Dis 1998; 57: 291-5. (Pubitemid 28351097)
32. Dekkers OM, Biermasz NR, Smit JW, Groot LE, Roelfsema F, Romijn JA, et al. Quality of life in treated adult craniopharyngioma patients. Eur J Endocrinol 2006; 154: 483-9.
33. Jansen AJ, Essink-Bot ML, Beckers EA, Hop WC, Schipperus MR, Van Rhenen DJ,. Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes. Br J Haematol 2003; 121: 270-4. (Pubitemid 36560593)
34. Ericsson A, Mannerkorpi K,. Assessment of fatigue in patients with fibromyalgia and chronic widespread pain: reliability and validity of the Swedish version of the MFI-20. Disabil Rehabil 2007; 29: 1665-70. (Pubitemid 351485786)
35. Fishbain DA, Lewis J, Cole B, Cutler B, Smets E, Rosomoff H, et al. Multidisciplinary pain facility treatment outcome for pain-associated fatigue. Pain Med 2005; 6: 299-304. (Pubitemid 41725954)
36. Lin JM, Brimmer DJ, Maloney EM, Nyarko E, Belue R, Reeves WC,. Further validation of the Multidimensional Fatigue Inventory in a US adult population sample. Popul Health Metr 2009; 7: 18.
37. Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y,. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 2008; 30: 1988-2004.
38. Hays RD, Stewart A,. Sleep measures. In:, Stewart A, Ware J, editors. Measuring functioning and well-being: the medical outcomes study approach. Durham (NC): Duke University Press; 1992. p. 235-59.
39. Mease PJ, Clauw DJ, Gendreau RM, Rao SG, Kranzler J, Chen W, et al. The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial. J Rheumatol 2009; 36: 398-409.
40. Hays RD, Martin SA, Sesti AM, Spritzer KL,. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med 2005; 6: 41-4.
41. Payne R, Mathias SD, Pasta DJ, Wanke LA, Williams R, Mahmoud R,. Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine. J Clin Oncol 1998; 16: 1588-93. (Pubitemid 28175785)
42. Allen RP, Kosinski M, Hill-Zabala CE, Calloway MO,. Psychometric evaluation and tests of validity of the Medical Outcomes Study 12-item Sleep Scale (MOS sleep). Sleep Med 2009; 10: 531-9.
43. Coyne KS, Zhou Z, Bhattacharyya SK, Thompson CL, Dhawan R, Versi E,. The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int 2003; 92: 948-54. (Pubitemid 37548272)
44. Wolfe F, Michaud K, Li T,. Sleep disturbance in patients with rheumatoid arthritis: evaluation by medical outcomes study and visual analog sleep scales. J Rheumatol 2006; 33: 1942-51. (Pubitemid 44571865)
45. Unruh ML, Hartunian MG, Chapman MM, Jaber BL,. Sleep quality and clinical correlates in patients on maintenance dialysis. Clin Nephrol 2003; 59: 280-8. (Pubitemid 36503547)
46. Rejas J, Ribera MV, Ruiz M, Masrramon X,. Psychometric properties of the MOS (Medical Outcomes Study) Sleep Scale in patients with neuropathic pain. Eur J Pain 2007; 11: 329-40. (Pubitemid 46216106)
47. Cappelleri JC, Bushmakin AG, McDermott AM, Dukes E, Sadosky A, Petrie CD, et al. Measurement properties of the Medical Outcomes Study Sleep Scale in patients with fibromyalgia. Sleep Med 2009; 10: 766-70.
48. Martin S, Chandran A, Zografos L, Zlateva G,. Evaluation of the impact of fibromyalgia on patients' sleep and the content validity of two sleep scales. Health Qual Life Outcomes 2009; 7: 64.
49. Seidenberg M, Haltiner A, Taylor MA, Hermann BB, Wyler A,. Development and validation of a Multiple Ability Self-Report Questionnaire. J Clin Exp Neuropsychol 1994; 16: 93-104. (Pubitemid 24051080)
50. Banos JH, LaGory J, Sawrie S, Faught E, Knowlton R, Prasad A, et al. Self-report of cognitive abilities in temporal lobe epilepsy: cognitive, psychosocial, and emotional factors. Epilepsy Behav 2004; 5: 575-9. (Pubitemid 39060715)
51. Martin R, Griffith HR, Sawrie S, Knowlton R, Faught E,. Determining empirically based self-reported cognitive change: development of reliable change indices and standardized regression-based change norms for the multiple abilities self-report questionnaire in an epilepsy sample. Epilepsy Behav 2006; 8: 239-45. (Pubitemid 43103854)
52. Donovan KA, Small BJ, Andrykowski MA, Schmitt FA, Munster P, Jacobsen PB,. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer 2005; 104: 2499-507. (Pubitemid 41691574)
53. Jim HS, Donovan KA, Small BJ, Andrykowski MA, Munster PN, Jacobsen PB,. Cognitive functioning in breast cancer survivors: a controlled comparison. Cancer 2009; 115: 1776-83.
54. Williams DA, Clauw DJ, Glass JM,. Perceived cognitive dysfunction in fibromyalgia syndrome. J Musculoskelet Pain 2011; 19: 66-75.
55. Owen RT,. Milnacipran hydrochloride: its efficacy, safety and tolerability profile in fibromyalgia syndrome. Drugs Today (Barc) 2008; 44: 653-60.